Clinical Trials in New York

Showing 7021-7040 of 22,668 trials

Saypha® VOLUME Lidocaine for Midface Augmentation

NCT05386030

The clinical investigation is a randomized, subject- and evaluator-blinded, active treatment controlled, multicenter, clinical investigation, to demonstrate the non inferiority of saypha® VOLUME Lidocaine to one of the devices approved for the same indication (Juvéderm® Voluma™ XC).

Moderate to Severe Midface Volume Deficit

Croma-Pharma GmbH562 participantsStarted Aug 2022

Scottsdale, Arizona, United States • Encino, California, United States • Fremont, California, United States +13 more locations

COMPLETEDPhase 1< 1 mile

Study of Harmine in Healthy Subjects

NCT05526430

The present study is a phase 1 dose escalation study of harmine in healthy volunteers. The primary goal of the trial is to determine the maximum tolerated dose of harmine.

Diabetes Mellitus

James Murrough27 participantsStarted Sep 2022

New York, New York, United States

Saypha® VOLUME Lidocaine for Midface Augmentation

Study of Harmine in Healthy Subjects

Find Trials by Condition in New York

Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation

Bile Acids in Acute Insulin Resistance

FluSAFE: Flu SMS Alerts to Freeze Exposure

The Syn-Sleep Study

PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

Twitter Based Social Support for Hispanic and Black Dementia Caregivers

Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

CLUSTER Trial for Outbreak Detection and Response

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Evaluating Treatment of ADHD in Children with Down Syndrome

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Nemaline Myopathy Clinical Research Network (NM-CTRN)

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)